Skip to main content

Advertisement

SpringerLink
Log in

Meningococcal Meningitis

  • CNS Infections
  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Meningococcal meningitis (MM) is the most common presentation of meningococcal disease and an important cause of morbidity and mortality worldwide. When MM is associated with shock, early recognition and treatment of shock is essential. No investigation should delay starting antibiotics once the diagnosis is suspected. Corticosteroids can be started at the same time as the antibiotics or just before, but this is not a specific recommendation for MM. Low-dose steroids should be used in meningococcal disease with refractory shock. Altered blood flow, cerebral edema, and raised intracranial pressure are problems that should be considered in all patients with MM and decreased consciousness level. When mechanical ventilation is required, the target carbon dioxide level is 4.0 to 4.5 kPa, with avoidance of hypocapnia. Seizures, although not frequent, can occur in MM and require prompt treatment. Other treatments, such as mannitol and activated protein C, should be avoided. Potential new treatments requiring further investigation include neuroprotection with hypothermia or glycerol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Cohn AC, MacNeil JR, Harrison LH, et al.: Changes in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010, 50(2):184–191.

    Article  PubMed  Google Scholar 

  2. Khatami A, Pollard AJ: The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010, 9(3):285–298.

    Article  PubMed  Google Scholar 

  3. Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369(9580):2196–2210.

    Article  PubMed  Google Scholar 

  4. MacLennan J, Kafatos G, Neal K, et al.: Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 2006, 12(6):950–957.

    PubMed  Google Scholar 

  5. Virji M: Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev 2009, 7(4):274–286.

    Article  CAS  Google Scholar 

  6. van Deuren M, Brandtzaeg P, van der Meer JW: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000, 13(1):144–166.

    Article  PubMed  Google Scholar 

  7. Rosenstein NE, Perkins BA, Stephens DS, et al.: Meningococcal disease. N Engl J Med 2001, 344(18):1378–1388.

    Article  CAS  PubMed  Google Scholar 

  8. Heckenberg SG, de Gans J, Brouwer MC, et al.: Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine 2008, 87(4):185–192.

    Article  PubMed  Google Scholar 

  9. Thompson MJ, Ninis N, Perera R, et al.: Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006, 367(9508):397–403.

    Article  PubMed  Google Scholar 

  10. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354(1):44–53.

    Article  PubMed  Google Scholar 

  11. Ovstebo R, Brandtzaeg P, Brusletto B, et al.: Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004, 42(7):2980–2987.

    Article  CAS  PubMed  Google Scholar 

  12. Proulx N, Frechette D, Toye B, et al.: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005, 98(4):291–298.

    Article  CAS  PubMed  Google Scholar 

  13. Gray SJ, Trotter CL, Ramsay ME, et al.: Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 2006, 55(Pt 7):887–896.

    Article  PubMed  Google Scholar 

  14. Borel T, Rose AM, Guillerm M, et al.: High sensitivity and specificity of the Pastorex latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger. Trans R Soc Trop Med Hyg 2006, 100(10):964–969.

    Article  CAS  PubMed  Google Scholar 

  15. Perea-Milla E, Olalla J, Sanchez-Cantalejo E, et al.: Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health 2009, 9:95.

    Article  PubMed  Google Scholar 

  16. Sudarsanam T, Rupali P, Tharyan P, et al.: Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev 2008, 1:CD005437.

    PubMed  Google Scholar 

  17. Brown EM, Fisman DN, Drews SJ, et al.: Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006. Antimicrob Agents Chemother 2010, 54(3):1016–1021.

    Article  CAS  PubMed  Google Scholar 

  18. Ellis-Pegler R, Galler L, Roberts S, et al.: Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003, 37(5):658–662.

    Article  CAS  PubMed  Google Scholar 

  19. Stella-Silvaa N, Oliveiraa SA, Feldman-Marzochib KB: Meningococcal disease: clinicopathological correlation] [in Spanish. Enferm Infecc Microbiol Clin 2003, 21(10):557–562.

    Article  PubMed  Google Scholar 

  20. Branco RG, Amoretti CF, Tasker RC: Meningococcal disease and meningitis. J Pediatr (Rio J) 2007, 83(2 Suppl):S46–S53.

    Article  Google Scholar 

  21. van de Beek D, de Gans J, McIntyre P, Prasad K: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007, 1:CD004405.

    PubMed  Google Scholar 

  22. van de Beek D, de Gans J: Should adults with suspected bacterial meningitis receive adjunctive dexamethasone? Nat Clin Pract 2008, 4(5):252–253.

    Article  Google Scholar 

  23. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347(20):1549–1556.

    Article  PubMed  Google Scholar 

  24. Kim KS: Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010, 10(1):32–42.

    Article  CAS  PubMed  Google Scholar 

  25. Marik PE, Pastores SM, Annane D, et al.: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36(6):1937–1949.

    Article  CAS  PubMed  Google Scholar 

  26. Branco RG, Russell RR: Should steroids be used in children with meningococcal shock? Arch Dis Child 2005, 90(11):1195–1196.

    Article  CAS  PubMed  Google Scholar 

  27. Moller K, Strauss GI, Thomsen G, et al.: Cerebral blood flow, oxidative metabolism and cerebrovascular carbon dioxide reactivity in patients with acute bacterial meningitis. Acta Anaesthesiol Scand 2002, 46(5):567–578.

    Article  CAS  PubMed  Google Scholar 

  28. Paulson OB, Brodersen P, Hansen EL, Kristensen HS: Regional cerebral blood flow, cerebral metabolic rate of oxygen, and cerebrospinal fluid acid-base variables in patients with acute meningitis and with acute encephalitis. Acta Med Scand 1974, 196(3):191–198.

    CAS  PubMed  Google Scholar 

  29. Odetola FO, Tilford JM, Davis MM: Variation in the use of intracranial-pressure monitoring and mortality in critically ill children with meningitis in the United States. Pediatrics 2006, 117(6):1893–1900.

    Article  PubMed  Google Scholar 

  30. Odetola FO, Bratton SL: Characteristics and immediate outcome of childhood meningitis treated in the pediatric intensive care unit. Intensive Care Med 2005, 31(1):92–97.

    Article  PubMed  Google Scholar 

  31. Bernard GR, Vincent JL, Laterre PF, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344(10):699–709.

    Article  CAS  PubMed  Google Scholar 

  32. Vincent JL, Nadel S, Kutsogiannis DJ, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9(4):R331–R343.

    Article  PubMed  Google Scholar 

  33. Nadel S, Goldstein B, Williams MD, et al.: Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369(9564):836–843.

    Article  CAS  PubMed  Google Scholar 

  34. Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346(8):549–556.

    Article  Google Scholar 

  35. Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346(8):557–563.

    Article  PubMed  Google Scholar 

  36. Azzopardi DV, Strohm B, Edwards AD, et al.: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009, 361(14):1349–1358.

    Article  CAS  PubMed  Google Scholar 

  37. Ackerman AD, Singhi S: Pediatric infectious diseases: 2009 update for the Rogers’ Textbook of Pediatric Intensive Care. Pediatr Crit Care Med 2010, 11(1):117–123.

    Article  PubMed  Google Scholar 

  38. Peltola H, Roine I, Fernandez J, et al.: Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007, 45(10):1277–1286.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. School of Clinical Medicine, Department of Paediatrics, Addenbrookes Hospital, University of Cambridge, Box 116, Hills Road, Cambridge, CB2 2QQ, UK

    Ricardo G. Branco MD & Robert C. Tasker MD, FRCP

Authors
  1. Ricardo G. Branco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert C. Tasker MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo G. Branco MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Branco, R.G., Tasker, R.C. Meningococcal Meningitis. Curr Treat Options Neurol 12, 464–474 (2010). https://doi.org/10.1007/s11940-010-0086-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-010-0086-5

Keywords

Search

Navigation